This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA), is for the procurement of 65IB, Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Shorla Oncology Inc., a for-profit, foreign-owned organization. The contract has a ceiling value of $250,000.00 and a period of performance from August 15, 2024 to August 14, 2029. The contract aims to provide the VA with a range of pharmaceutical and hematology-related products. While no...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Autolus Inc., a foreign-owned for-profit organization, aims to procure drugs, pharmaceuticals, and hematology-related products. The contract has a ceiling value of $250,000.00 and a period of performance from March 4, 2025, to August 31, 2025. This is an interim agreement under FSS Schedule 65 I B, which covers the specified product categories. The...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Provepharm Inc., a foreign-owned, self-certified small disadvantaged business organization. The contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract has a ceiling value of $25,000.00 and a performance period ending on March 15, 2023. It was awarded on October 10, 2022 and is not set aside...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued at up to $25,000.00, is an interim agreement under FSS Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Iovance Biotherapeutics Manufacturing LLC, a for-profit organization. The contract has a period of performance lasting until October 14, 2024. No...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Ars Pharmaceutical Operations, Inc. The $1,025,000.00 contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from September 15, 2024 to March 14, 2025 and was set up as a multiple award vehicle with no set-asides. As an FSS contract, the awarded prime contractor...
The Federal Supply Schedule (FSS) contract award 36F79724D0047 was issued by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract has a ceiling value of $1,188,000.00 and a period of performance through December 31, 2028. The contract was awarded to Nnodum Pharmaceuticals Corp, a minority-owned and SBA-certified 8(a) small disadvantaged business. The contract is for the procurement of 65 I B, DRUGS,...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, aims to procure a variety of drugs, pharmaceuticals, and hematology-related products. The contract has a total ceiling value of $23,163,260.00 and a period of performance that extends through April 14, 2028. The prime contractor for this multiple-award FSS contract is Spectrum Pharmaceuticals, Inc., a for-profit organization and manufacturer of goods. The...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Aurobindo Pharma USA Inc., a foreign-owned for-profit organization. The contract was awarded on March 15, 2020, with a ceiling value of $700,000.00 and a period of performance ending on March 14, 2026. The contract scope covers the procurement of drugs, pharmaceuticals, and hematology-related products under the General Services...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, is an interim agreement under FSS Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Genmab US Inc., a foreign-owned for-profit organization. The contract has a ceiling value of $25,000.00 and a period of performance through November 15, 2023. It was awarded on June 17, 2023 without any set-asides. The contract aims to...